Contributing to the science of vascular disease

The UC Davis Vascular Center clinical research program is dedicated to contributing to the science of vascular disease through clinical trials. The center's research program is comprehensive and specifically designed to find better, safer ways to treat patients with peripheral arterial disease, also known as PAD. Offering national and innovative clinical trials is one of the many ways that UC Davis helps advance medicine worldwide.

Here are the current studies focusing on investigational therapies and devices:

  • Best-Registry - The primary objective of the BEST-Registry is to enroll patients excluded from the BEST-CLI Trial and thereby assess real-world therapeutic strategies, clinical outcomes, and costs associated with critical limb ischemia. By enrolling patients excluded from the BEST-CLI trial, data from the BEST-Registry will also provide important context to the results of the BEST-CLI Trial.
  • AAA QI Project - The aim of the study is to increase the rate of abdominal aortic aneurysm (AAA) screening through electronic medical record (EMR) based quality improvement program and outreach to patients and PCPs for patients at UC Davis Medical Center. This will lead to lowering AAA-related mortality.
  • PEO - The aim of the study is to determine how patient activation affects outcomes for patients with vascular diseases. The study is currently screening and enrolling patients. 

For more information

For more information about our current research studies contact the UC Davis Division of Vascular Surgery clinical research coordinator, at 916-734-4156. See also general information about UC Davis Health clinical trials.